Stefanie Van den Bremt

KU Leuven, Onze Lieve Vrouwziekenhuis Hospital

Papers

2

Total Citations

135

H-Index

2

About

Stefanie Van den Bremt is a leading researcher at the intersection of industrial biotechnology and clinical diagnostics. Her most prominent work focuses on metabolic engineering of *Saccharomyces cerevisiae* for enhanced bioethanol production. In a landmark 2015 study, she pioneered large-scale robot-assisted genome shuffling to develop industrial yeast strains with dramatically increased ethanol tolerance—a breakthrough that directly addresses the bottleneck of arrested fermentation in biofuel production. This highly cited work (105 citations) has significant implications for improving bioethanol yields and process efficiency. Beyond biotechnology, Van den Bremt has contributed to medical diagnostics, notably investigating variability in automated antinuclear antibody detection for autoimmune disease testing (30 citations). Her research demonstrates a rare versatility, applying high-throughput automation and genetic engineering to both sustainable energy solutions and clinical laboratory science. Van den Bremt’s work exemplifies how interdisciplinary approaches—combining robotics, genomics, and industrial microbiology—can solve real-world challenges in energy and healthcare.

Research Focus

Key Achievements

2
H-Index
2
Papers
135
Total Citations
68
Avg Citations/Paper
🏆 Most Cited Paper
Large-scale robot-assisted genome shuffling yields industrial Saccharomyces cerevisiae yeasts with increased ethanol tolerance
105 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: KU Leuven, Onze Lieve Vrouwziekenhuis Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago